Drug War '07: drug giants Novo Nordisk and Sanofi-Aventis have been sparring recently over their insulin pen designs. Novo alleges Sanofi has stolen its design ideas, basically. Check out Bev's post on this to learn more.The reason it's such a big deal to them is money. The insulin pen could be super-lucrative for investors. Meanwhile, here's some news that's bound to get big pharma even more excited: a new study reports that insulin pens are cheaper and more effective than insulin shots.
Why so good? Fewer trips to the emergency room and fewer visits to the doctor. Insulin pens boast a pre-measured dosing system, with each dose of insulin contained in a single, disposable cartridge. This eliminates the risk of over- or under-dosing, says senior author of the study, Dr. Rajesh Balkrishnan of Ohio State University in Columbus. The researchers say that study participants who used an insulin pen instead of a regular syringe ended up reducing their annual healthcare costs by nearly $17,000. Wow.
What I'm not clear on here is whether or not they factored in the added expense of upgrading from syringes to insulin pens.
Want to know more? The study has been published in the latest issue of Clinical Therapeutics, but you can click here to read a summary.


A study suggests 
Anybody who has been granted the dubious distinction of multiple blood glucose readings a day will appreciate the lively approach my endocrinologist has applied to diabetes management. As his cartoon-depicted alter ego, Dr. Grady brings you straightforward explanations of the medical issues in the form of comic strips. His approach is the 







